What is Guilin Sanjin Pharmaceutical Co., Ltd.'s (002275.SZ) StockRank?

MoatMap's StockRank for Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) is 96/100, with a Strong Buy signal. This is a composite score combining Quality (79), Value (61), and Momentum (53) factor ranks across MoatMap's 20,000+ stock universe.

Does Guilin Sanjin Pharmaceutical Co., Ltd. have an economic moat?

Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) has a Quality factor score of 79/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Guilin Sanjin Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Guilin Sanjin Pharmaceutical Co., Ltd. in?

Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002275.SZ

STRONG BUYREMOVE

Guilin Sanjin Pharmaceutical Co., Ltd. · Healthcare · China · $1.2B · Avg Vol: $4M/d

StockRank

P/E (TTM)

16.4x

ROE

14.0%

D/E

0.1x

Dividend %

3.9%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Guilin Sanjin is a Traditional Chinese Medicine producer with localized domestic demand and no exposure to our global structural themes such as advanced packaging or energy transition.

COMPANY DESCRIPTION

Guilin Sanjin Pharmaceutical Co., Ltd. manufactures traditional Chinese medicine (TCM), specializing in lozenges and urinary tract treatments. It holds iconic, household brand names in China with proprietary TCM formulations that enjoy strong consumer loyalty. The company is a highly profitable, niche leader in the OTC traditional Chinese medicine market.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	290M	321M	324M	302M	1.4%
EPS	0.08	0.11	0.13	0.11	9.7%
Shares	588M	588M	588M	588M	0.0%
Debt	69M	78M	88M	76M	3.3%
Equity	416M	416M	445M	472M	4.3%
Op CF	78M	81M	87M	105M	10.2%
Inv CF	-12M	-14M	-52M	-63M	—
Fin CF	-101M	-53M	-31M	-55M	—

PRICE (1M)-14.6%

SMA 50SMA 200

$1.83

RSI (14)

31.8

52W High

$2.48

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

16.0%87.0

ROE

14.0%80.8

GP/Assets

37.9%76.8

Op. Margin

28.1%90.5

FCF/Assets

10.8%88.9

Piotroski

—83.4

Int. Cover

28.0x78.5

D/E Ratio

0.13x61.5

Current Ratio

3.97x63.7

Value

P/E (TTM)

16.4x68.3

EV/EBITDA

10.1x42.0

P/FCF

117.6x66.7

P/B

2.2x51.5

P/S

3.5x51.3

Div Yield

3.9%82.5

Momentum

52W High %

74%62.9

RS 6M

-25%50.6

SMA 50/200

0.96x50.8

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+23%36.2

Q Growth

19%62.0

FUNDAMENTALS

Market Cap

$1.2B

P/E (Forward)

13.3x

Gross Margin

76.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002275.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002275.SZ	Guilin Sanjin Pharmaceutical Co., Ltd.(you)	$1.2B	96	STRONG BUY
000650.SZ	Renhe Pharmacy Co.,Ltd	$1.1B	97	STRONG BUY
000915.SZ	Shandong Wit Dyne Health Co.,Ltd.	$946M	96	STRONG BUY
1681.HK	Consun Pharmaceutical Group Limited	$1.5B	98	STRONG BUY
600572.SS	Zhejiang CONBA Pharmaceutical Co.,Ltd.	$1.6B	94	STRONG BUY
000989.SZ	Jiuzhitang Co., Ltd.	$1.0B	91	STRONG BUY
600285.SS	Henan Lingrui Pharmaceutical Co., Ltd.	$1.8B	96	STRONG BUY
002737.SZ	Sunflower Pharmaceutical Group Co.,Ltd	$1.1B	88	STRONG BUY
600267.SS	Zhejiang Hisun Pharmaceutical Co., Ltd.	$1.8B	95	STRONG BUY
600211.SS	Tibet Rhodiola Pharmaceutical Holding Co.	$1.8B	96	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) — Stock Score Summary

Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) has a MoatMap StockRank of 96/100 based on Quality (79/100), Value (61/100), and Momentum (53/100) factor scores. The current signal is STRONG BUY. Guilin Sanjin is a Traditional Chinese Medicine producer with localized domestic demand and no exposure to our global structural themes such as advanced packaging or energy transition.

Key Financial Metrics

Price	$1.83
Market Cap	$1.2B
P/E (TTM)	16.39
P/E (Forward)	13.28
Price/Book	2.23
Return on Equity	14.0%
Return on Invested Capital	16.0%
Debt/Equity	13.23
Gross Margin	76.3%
Operating Margin	28.1%
Revenue Growth	12.5%
Dividend Yield	3.9%
Free Cash Flow	$10M

Guilin Sanjin Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Guilin Sanjin Pharmaceutical Co., Ltd.’s (002275.SZ) StockRank?: MoatMap’s StockRank for Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) is 96/100, with a Strong Buy signal. It is a composite of Quality (79), Value (61), and Momentum (53) factor ranks across MoatMap’s 20,000+ stock universe.
Does Guilin Sanjin Pharmaceutical Co., Ltd. have an economic moat?: Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) has a Quality factor score of 79/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Guilin Sanjin Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Guilin Sanjin Pharmaceutical Co., Ltd. in?: Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).